171 related articles for article (PubMed ID: 9636683)
1. Cytokine release by macrophages after interacting with CSF-1 and extracellular matrix proteins: characteristics of a mouse model of inflammatory responses in vitro.
Kremlev SG; Chapoval AI; Evans R
Cell Immunol; 1998 Apr; 185(1):59-64. PubMed ID: 9636683
[TBL] [Abstract][Full Text] [Related]
2. CSF-1 (M-CSF) enhances the inflammatory response of fibronectin-primed macrophages: pathways involved in activation of the cytokine network.
Kremlev SG; Chapoval AI; Evans R
Nat Immun; 1998; 16(5-6):228-43. PubMed ID: 11061591
[TBL] [Abstract][Full Text] [Related]
3. Differential sensitivity of mouse mononuclear phagocytes to CSF-1 and LPS: the potential in vivo relevance of enhanced IL-6 gene expression.
Kamdar SJ; Chapoval AI; Phelps J; Fuller JA; Evans R
Cell Immunol; 1996 Dec; 174(2):165-72. PubMed ID: 8954616
[TBL] [Abstract][Full Text] [Related]
4. Modulation of colony-stimulating factor-1 receptors on macrophages by tumor necrosis factor.
Shieh JH; Peterson RH; Warren DJ; Moore MA
J Immunol; 1989 Oct; 143(8):2534-9. PubMed ID: 2551961
[TBL] [Abstract][Full Text] [Related]
5. MRL/lpr and MRL+/+ macrophage DNA synthesis in the absence and the presence of colony-stimulating factor-1 and granulocyte-macrophage colony-stimulating factor.
Hamilton JA; Chan J; Byrne RJ; Bischof RJ; Jaworowski A; Kanagasundaram V
J Immunol; 1998 Dec; 161(12):6802-11. PubMed ID: 9862711
[TBL] [Abstract][Full Text] [Related]
6. Induction of tumour necrosis factor receptor-expressing macrophages by interleukin-10 and macrophage colony-stimulating factor in rheumatoid arthritis.
Takasugi K; Yamamura M; Iwahashi M; Otsuka F; Yamana J; Sunahori K; Kawashima M; Yamada M; Makino H
Arthritis Res Ther; 2006; 8(4):R126. PubMed ID: 16859503
[TBL] [Abstract][Full Text] [Related]
7. Effects of prolactin and metoclopramide on macrophage cytokine gene expression in late sepsis.
Zhu XH; Zellweger R; Wichmann MW; Ayala A; Chaudry IH
Cytokine; 1997 Jun; 9(6):437-46. PubMed ID: 9199878
[TBL] [Abstract][Full Text] [Related]
8. Systemic inflammatory response to exhaustive exercise. Cytokine kinetics.
Suzuki K; Nakaji S; Yamada M; Totsuka M; Sato K; Sugawara K
Exerc Immunol Rev; 2002; 8():6-48. PubMed ID: 12690937
[TBL] [Abstract][Full Text] [Related]
9. TNF-alpha enhances colony-stimulating factor-1-induced macrophage accumulation in autoimmune renal disease.
Moore KJ; Yeh K; Naito T; Kelley VR
J Immunol; 1996 Jul; 157(1):427-32. PubMed ID: 8683148
[TBL] [Abstract][Full Text] [Related]
10. Methods of in vitro macrophage maturation confer variable inflammatory responses in association with altered expression of cell surface dectin-1.
Gersuk GM; Razai LW; Marr KA
J Immunol Methods; 2008 Jan; 329(1-2):157-66. PubMed ID: 17997408
[TBL] [Abstract][Full Text] [Related]
11. Polymicrobial sepsis selectively activates peritoneal but not alveolar macrophages to release inflammatory mediators (interleukins-1 and -6 and tumor necrosis factor).
Ayala A; Perrin MM; Kisala JM; Ertel W; Chaudry IH
Circ Shock; 1992 Mar; 36(3):191-9. PubMed ID: 1611704
[TBL] [Abstract][Full Text] [Related]
12. Induction of murine peritoneal macrophage colony-forming cells by peritoneal administration of macrophage inflammatory protein-1 alpha.
Chen B; Chou TH; Sensenbrenner L
Exp Hematol; 1993 Nov; 21(12):1591-6. PubMed ID: 8405240
[TBL] [Abstract][Full Text] [Related]
13. TNF-alpha binds to the N-terminal domain of fibronectin and augments the beta 1-integrin-mediated adhesion of CD4+ T lymphocytes to the glycoprotein.
Alon R; Cahalon L; Hershkoviz R; Elbaz D; Reizis B; Wallach D; Akiyama SK; Yamada KM; Lider O
J Immunol; 1994 Feb; 152(3):1304-13. PubMed ID: 7905501
[TBL] [Abstract][Full Text] [Related]
14. Regulation of tumor necrosis factor (TNF) release by murine peritoneal macrophages: role of cell stimulation and specific phagocytic plasma membrane receptors.
Stein M; Gordon S
Eur J Immunol; 1991 Feb; 21(2):431-7. PubMed ID: 1999225
[TBL] [Abstract][Full Text] [Related]
15. Transgenic expression of CSF-1 in CSF-1 receptor-expressing cells leads to macrophage activation, osteoporosis, and early death.
Wei S; Dai XM; Stanley ER
J Leukoc Biol; 2006 Dec; 80(6):1445-53. PubMed ID: 16973889
[TBL] [Abstract][Full Text] [Related]
16. Macrophage activation by a DNA/cationic liposome complex requires endosomal acidification and TLR9-dependent and -independent pathways.
Yasuda K; Ogawa Y; Yamane I; Nishikawa M; Takakura Y
J Leukoc Biol; 2005 Jan; 77(1):71-9. PubMed ID: 15496451
[TBL] [Abstract][Full Text] [Related]
17. Effect of granulocyte macrophage-colony stimulating factor on extracellular matrix deposition by dermal fibroblasts from patients with scleroderma.
Postiglione L; Ladogana P; Montagnani S; di Spigna G; Castaldo C; Turano M; Bruno EM; Di Meglio F; Riccio A; Rossi G
J Rheumatol; 2005 Apr; 32(4):656-64. PubMed ID: 15801021
[TBL] [Abstract][Full Text] [Related]
18. Activities of granulocyte-macrophage colony-stimulating factor and interleukin-3 on monocytes.
Suzuki H; Katayama N; Ikuta Y; Mukai K; Fujieda A; Mitani H; Araki H; Miyashita H; Hoshino N; Nishikawa H; Nishii K; Minami N; Shiku H
Am J Hematol; 2004 Apr; 75(4):179-89. PubMed ID: 15054806
[TBL] [Abstract][Full Text] [Related]
19. Recombinant guinea pig CCL5 (RANTES) differentially modulates cytokine production in alveolar and peritoneal macrophages.
Skwor TA; Cho H; Cassidy C; Yoshimura T; McMurray DN
J Leukoc Biol; 2004 Dec; 76(6):1229-39. PubMed ID: 15377675
[TBL] [Abstract][Full Text] [Related]
20. Effect of macrophage colony-stimulating factor (M-CSF) on mouse immune responses in vivo.
Sakurai T; Wakimoto N; Yamada M; Shimamura S; Motoyoshi K
Immunopharmacol Immunotoxicol; 1998 Feb; 20(1):79-102. PubMed ID: 9543701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
